DIRECTLY COMPRESSIBLE MATRIX FOR CONTROLLED RELEASE OF SINGLE DAILY DOSES OF CLARITHROMYCIN
Farmaceutska formulacija za kontrolirano odpustanje za peroralnu jednostruku dnevnu primjenu, naznacena time, da sadrzi klaritromicin i smjesu masne i hidrofilne komponente. Patent sadrzi jos 14 patentnih zahtjeva. The invention refers to an improved pharmaceutical formulation for controlled release...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | hrv ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Farmaceutska formulacija za kontrolirano odpustanje za peroralnu jednostruku dnevnu primjenu, naznacena time, da sadrzi klaritromicin i smjesu masne i hidrofilne komponente. Patent sadrzi jos 14 patentnih zahtjeva.
The invention refers to an improved pharmaceutical formulation for controlled release of clarithromycin or its derivatives, enabled by a novel combined matrix consisting of a fatty and a hydrophilic component, whereto also a surfactant and a pH-modulator may be added when an additional influence on the release profile of the active substance is desired. |
---|